Sample characteristics | n (%) | Mean (95% CI) |
---|---|---|
Gender (%) | ||
 Male | 49 (61.25) |  |
 Female | 31 (38.75) |  |
Age (years) |  | 52.91 (49.36–56.47) |
Duration of HD (years) |  | 4.36 (3.45–5.27) |
Diuresis Volume (mL) |  | 435.91 (263.63–608.18) |
Kt/v |  | 1.46 (1.37–1.56) |
Comorbidities | ||
 Systemic hypertension | 73 (91.30) |  |
 Diabetes | 20 (25.00) |  |
 Obesity | 11 (13.80) |  |
 Others | 27 (33.80) |  |
DXA | ||
 Body fat (%) |  | 29.21 (26.81–31.61) |
 Appendicular lean mass (kg) |  | 18.04 (16.85–19.23) |
 BMD total (g/cm3) |  | 0.99 (0.96–1.04) |
 BMD spine (g/cm3) |  | 1.00 (0.95–1.07) |
 BMD hip (g/cm3) |  | 0.83 (0.79–0.88) |
Blood clinical biomarkers | ||
 Vitamin D (ng/mL) |  | 36.08 (32.70–39.46) |
 PTH (pg/mL) |  | 343.09 (293.63–392.54) |
 CRP (mL/L) |  | 9.29 (5.57–13.01) |
 Hb (g/dL) |  | 10.83 (10.50–11.16) |
 Alkaline phosphatase (U/L) |  | 134.30 (114.56–154.04) |
 Ferritin (ng/mL) |  | 415.76 (343.57–487.95) |